Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc. is a medical technology company focused on advancing the surgical treatment of bunions and related midfoot deformities. The company's flagship product is the Lapiplasty 3D Bunion Correction System, a combination of proprietary instruments, implants, and surgical methods designed to… From the company’s description.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Treace Medical Concepts, Inc. does
In the company’s own words
Treace Medical Concepts, Inc. is a medical technology company focused on advancing the surgical treatment of bunions and related midfoot deformities. The company's flagship product is the Lapiplasty 3D Bunion Correction System, a combination of proprietary instruments, implants, and surgical methods designed to correct all three planes of bunion deformity and stabilize the unstable first tarsometatarsal joint. The Lapiplasty System represents a significant advancement over traditional two-dimensional surgical approaches, which historically resulted in recurrence rates as high as 78 percent.
Beyond its core Lapiplasty offering, Treace has developed a comprehensive portfolio of complementary products addressing various bunion classifications and related foot pathologies. These include the Adductoplasty Midfoot Correction System for midfoot deformities, the Nanoplasty and Percuplasty minimally invasive osteotomy systems, the SpeedMTP System for great toe fusions, and the SpeedPlate Rapid Compression Implant platform. The company also offers the IntelliGuide patient-specific instrumentation technology, which uses CT scan data to create three-dimensional preoperative plans and patient-specific cut guides. Additional products include the Hammertoe PEEK Fixation System and various specialized sterile surgical instruments.
The company markets and sells its products in the United States through a direct employee sales force supplemented by independent sales agencies. As of December 31, 2025, Treace maintained a field sales fleet of 297 team members. The company targets approximately 8,000 surgical podiatrists and 2,600 orthopaedic surgeons with foot and ankle specializations in the United States. Treace operates in a market where approximately 1.1 million Americans are annual surgical candidates for bunion procedures, representing a total addressable market opportunity exceeding five billion dollars.
The company differentiates itself through extensive surgeon education and training programs, including simulated surgical workshops and advanced technical training. Treace maintains a robust clinical evidence program with multiple prospective, multicenter post-market studies supporting its products' safety and efficacy. The company's intellectual property portfolio includes 95 granted U.S. patents and 39 granted foreign patents covering core Lapiplasty and Adductoplasty technologies and related innovations. More information is available at www.treacemedical.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Surgical & Medical Instruments
- Headquarters
- PONTE VEDRA, FL
- Fiscal year end
- December
- CIK
- 1630627
- SIC
- 3841
Financial performance, year by year
Fiscal 2021–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Treace Medical Concepts, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Treace Medical Concepts, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Could not be determined for this company: bond issues.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Treace Medical Concepts, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Treace Medical Concepts, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Treace Medical Concepts, Inc.'s last four quarterly filings that the numbers alone won't show?”